Core Insights - Gentherm expands its partnership with DUOMED into France, enhancing patient temperature management technologies across Europe [1][2] - DUOMED will distribute Gentherm's full patient temperature management portfolio, including the Astopad and Vytil-branded systems [2] - The partnership aims to leverage DUOMED's strong presence and relationships in Europe to improve healthcare delivery [3][4] Company Overview - Gentherm is a global leader in thermal management and pneumatic comfort technologies, with a diverse product range in automotive and medical sectors [5] - In 2024, Gentherm reported annual sales of approximately $1.5 billion and secured $2.4 billion in new automotive business awards [5] - DUOMED, part of the Palex group, specializes in medical technology sales, consultancy, and support, focusing on high-quality solutions for healthcare professionals [6] Product Insights - The Astopad resistive warming system and Vytil-branded convective warming system are key offerings in the partnership [2] - Early feedback from French clinicians indicates a preference for Vytil blankets due to their superior quality compared to competitors [4] - Vytil products are recognized for their quality, safety, and value, with a focus on usability and innovation [7]

Core Viewpoint - Hong Kong is experiencing significant demographic changes due to aging, leading to a diversified elderly care industry, exemplified by Anew Health Limited's IPO plans and growth in pain management services [1][6]. Company Overview - Anew Health Limited plans to raise $15 million by issuing 3.75 million shares at $4 each, aiming for a Nasdaq listing under the ticker "AVG" [1]. - The company has been operating since 2007, focusing on pain management and health services, leveraging a blend of traditional Chinese medicine and advanced energy treatment technologies [1][2]. Financial Performance - For the fiscal year ending March 31, 2024, Anew Health reported revenues of approximately $40.8 million, a 49.6% increase from $27.3 million in the previous year [3]. - The net profit surged by 122.1%, reaching $11.73 million compared to $5.28 million in the prior year, indicating a successful doubling of profits [2][4]. - The gross margin improved significantly from about 62.7% to approximately 72.3%, reflecting enhanced profitability of the company's services [2]. Customer Base and Service Offering - The company served 8,692 clients in fiscal year 2024, a slight increase from 8,654 clients in 2023, indicating stable customer retention [2]. - Pain management and health services accounted for 99.87% of total revenue, while healthcare product sales contributed less than 1% [2]. Market Trends - The elderly population in Hong Kong aged 65 and above is projected to rise from 18.4% of the total population to 30.9% by 2036, driving demand for elderly care services [6]. - The non-drug pain management customer base is expected to grow from approximately 206,600 in 2012 to a forecasted 281,400 by 2025, with a compound annual growth rate of 2.4% [6]. Investment and Cash Flow - Despite the increase in net profit, the net cash flow from operating activities decreased by 46.3%, raising concerns about the quality of earnings [4][5]. - The company significantly reduced its investment cash outflow by 90.6%, from $1.98 million to $186,038, possibly due to strategic adjustments or cash flow pressures [5]. Regulatory and Operational Considerations - Anew Health's products have not received approval from regulatory bodies like the FDA or EMA, which may pose risks to its business operations [9]. - The company does not operate as a registered medical clinic under Hong Kong law, which may limit its service offerings and revenue diversification [9].

Core Viewpoint - The article highlights the advancements and innovations of Bingbai Technology in the field of spatial intelligence, emphasizing its dual technology approach of 3D spatial digital reconstruction and AI semantic understanding, which enables AI to perceive and interact with the physical world effectively [5][7]. Group 1: Company Innovations - Bingbai Technology has developed a series of innovative products based on its core technologies, holding 14 invention patents and 23 software copyrights, with several products surpassing international competitors in key metrics [5][6]. - The Mirauge3D, a distributed computing engine for imaging, boasts the highest success rate in the industry for aerial triangulation and has served nearly 10,000 clients across various sectors [6]. - The Rusa rapid 3D scene restoration system allows for quick data collection and modeling using mobile devices, significantly reducing the time for traffic accident scene processing from 40 minutes to 10 minutes [6][11]. Group 2: Applications of Spatial Intelligence - The TrackSight system enhances the precision of tracking and analyzing dynamic objects, achieving sub-pixel recognition accuracy and filling a gap in high-precision dynamic spatial analysis in the domestic market [8]. - The DroneSwarm system enables real-time 2D and 3D reconstruction and autonomous operation of drone swarms, achieving a mapping speed 10 times faster than traditional methods and at a cost only 10% of laser modeling [9]. - DroneSwarm has demonstrated significant value in military reconnaissance, emergency rescue, and precision agriculture, marking a shift from passive execution to proactive intelligent perception and decision-making in drone technology [9]. Group 3: Industry Insights - The concept of spatial intelligence, introduced by Stanford professor Fei-Fei Li, is seen as a key milestone in AI development, transitioning from mere visual recognition to a comprehensive understanding and operation of the physical world [7]. - Bingbai Technology's approach to addressing industry needs, such as improving traffic accident handling efficiency, showcases its ability to respond quickly to market demands through technological innovation [11].

洞见 （DJ00123987） ——不一样的观点，不一样的故事，3000万人订阅的微信大号。点击标 题下蓝字"洞见"关注，我们将为您提供有价值、有意思的延伸阅读。 溯源归一牧场，带你现场看牛牛 小孩喝了长高，大人喝了强身健体 预约直播，喝优质好奶 都说人是视觉动物，我倒觉得，人更像是嗅觉动物。 毕竟，谁不喜欢香香的味道呢？ 要是在街上闻到一股好闻的香气，即便未见其人，单凭这股香气，就天然的让人生出几分好感。 有时我在大街上、餐厅里，闻到好闻的味道，也都忍不住侧目回头，寻找香气主人的倩影。 香水就如同女人的 隐形战衣 。 不仅能瞬间提升个人魅力，也能成就别人对你的第一印象。 难怪德国作家帕特里克·聚斯金德也在《香水》里写道： "谁掌握了气味，谁就掌握了别人的心。" 尤其是近两年大火的伪体香—— 一种喷起来不像香水，更像是身体里隐约散发出的、类似少女体香的香气，更为撩人。 香感隐约不扰人，尤其符合我们内敛的中国式气味审美。 同时这种若有似无、自然到需要再靠近一些才能被捕捉到的少女体香，就像是无声的诱惑般，暗 戳戳地撩拨你的心弦，叫人欲罢不能。 约会前喷两下，近距离接触时分分钟让对方乱了阵脚。 也因它闻起来像自身体 ...

The Swarm Raises Funding, Backed by HubSpot Ventures, Launches Clay Integration and Developer APIJune 11, 2025 7:58 PM EDT | Source: GetFeaturedSan Francisco, California--(Newsfile Corp. - June 11, 2025) - The Swarm, a San Francisco-based company, announced today that it has raised funding to expand its relationship mapping technology. The latest round includes participation from HubSpot Ventures, Motivate Ventures, and TRAC VC, signaling growing demand for network mapping tech that enables co ...

撰文丨王聪 编辑丨王多鱼 排版丨水成文 该研究利用 跨域协同学习 （CdCL） 算法和 超广角 （UWF） 眼底图像，开发了一种 AI 模型—— WARM ， 能够识别诊断多达 25 种眼底病，并给出相应的转 诊建议。 欢迎进群分享/讨论 生物医学领域 AI 智能体 研究进展 传统的眼底照相机主要用于眼底筛查，其覆盖的眼底区域仅约 15%，提供的病变信息有限。相比之下，新兴的 超广角扫描激光检眼镜 能够在一次无创拍摄中捕 捉到高达 200° 广角的视网膜 （覆盖眼底面积的 82%） ，甚至无需散瞳。该技术能够高效识别周边视网膜和后部视网膜区域，从而有助于在一张图像中诊断可 能存在的黄斑或周边视网膜及血管病变。 眼底病 （OFD） 相关视力损害是全球主要的公共卫生问题之一。目前，全球有超过 22 亿人患有视力损害或失明，其中中国有 5500 万人，眼底病患者占所有失 明病例的一半以上。预计到 2050 年，由于全球人口老龄化和增长，失明人数可能会增加两倍，这可能会严重降低生活质量，造成经济负担，并危及整体公共健 康。然而，眼底病患者数量众多，而全球范围内可及的视网膜专家数量却严重不足，这进一步加大了大规模及时干 ...

洞见 （DJ00123987） ——不一样的观点，不一样的故事，2000万人订阅的微信大号。点击标题下蓝字"洞见"关注，我们将为您提供有价值、有意 思的延伸阅读。 夏季好物专场， 吃、穿、玩应有尽有 预约 直播 ，抢好物福利 大家有没有发现最近几年我们的国货在开挂的路上，越走越远！ 高颜值+高性价比+超好用， 怪不得我一看消费记录，接近一半的都是国货单品。 相比于之前"质量堪忧，包装廉价"的刻板印象，短短几年，国货市场已经迅速崛起，一个个品牌如雨后春笋般冒出来，让人应接不暇。 一些新锐国货： 诗朗、片仔癀、马应龙 等，也一直在用专业实力征服国人。 国货崛起，让 中国制造 这四个大字也有了更特别的意义。 今天就趁这个机会， 再 给大家盘点几款真正实力强、性价比高的国货之光， 让你花最少的钱，也能买到最好的东西： 这些是我们经过长时间的 试用、测评 ， 社群读者好评 反馈后，选出的 使用体验好 、 价格良心 、 效果出众 的"优质国货"。 请大家耐心的看完本文，您的认可是对"国货崛起"贡献的一份力量。 洞见 x 品质国货 点击下图 立即购买↓ 在线客服、查询 订单物流 、售后处理 关注 "洞见好物馆" 不迷路 ▽ ...

所谓柔性机器人，不仅仅使用"柔性"的材料，更是科技彰显的柔软的"人文关怀"。姜汉卿认 为："科技最美好的意义，是创造人类原本不敢想象的需求，而非替代人类。未来的机器人将不再是冰 冷的金属，而是能感知、适应甚至'理解'人类的伙伴。" 机械臂从"百炼钢化为绕指柔"是如何做到的？ 西湖交互创始人、西湖大学工学院机械工程讲席教授姜汉卿，长期从事基于折纸与剪纸的机械超材 料在机器人及人机交互领域的应用研究。"不依赖分子或晶体结构，机械超材料的功能全部来自设计的 精巧构型。"姜汉卿举了一个日常生活中很常见的例子——超市里的真空包装大米，真空时大米十分坚 硬，放气后则变得软趴趴。机械臂里的"珠串"结构，真空时珠子紧紧绞在一起，刚度暴增；充气后珠子 松开，就能灵活弯曲。 从实验室走向应用，大有可为。据统计，中国60岁以上人口已超2.8亿，护理人员缺口超千万。"我 们首个目标正是锁定养老护理与服务机器人市场。"姜汉卿介绍，通过精准的刚柔转换，HEART系列机 器人可在失能老人护理、康复辅助、物资配送等场景中提供安全可靠的解决方案，比如，在护理过程中 自动感知人体触碰并柔化动作，避免意外伤害。 当前，市面上大多数机器人还扮演着" ...

Company Overview - Potbelly Corporation is a neighborhood sandwich concept that has been serving customers for over 40 years, offering warm sandwiches, signature salads, hand-dipped shakes, and other fresh menu items [2] - The company operates more than 440 shops across the United States, including over 90 franchised locations [2] Upcoming Investor Conferences - The company will participate in the Craig-Hallum 22nd Annual Institutional Investor Conference in Minneapolis, MN on May 28, 2025, holding one-on-one meetings with investors [3] - On June 4, 2025, Potbelly will present at the William Blair 45th Annual Growth Stock Conference in Chicago, IL, with the presentation scheduled to begin at 4:40 PM Central Time, which will be webcast live [3]

报名：首届全球心血管大会 | 最新议程 合作伙伴征集：2025全球手术机器人大会 心未来 近日， 上海微创心脉医疗科技（集团）股份有限公司 （以下简称 "心脉医疗 "）公布了其 2025年第一 季度财报 。 报告显示，公司一季度营业收入为 3.32亿元 ， 同比 下降7.23% ；归母净利润为 1.30亿元 ，同比下降 29.66%；扣非归母净利润为1.22亿元，同比下降31.27%；基本每股收益 1.05元 。 主动 脉 介入 领域 # 主要财务数据 # 财务状况 费用情况 营业收入： 2025年第一季度，心脉医疗实现营业收入 3.32亿元 ， 同比 下降7.23% 。 净利润： 归母净利润为 1.3亿元 ， 同比 下降29.66% ；扣非净利润为1.22亿元，同比下降 31.27%。 毛利率与净利率： 毛利率为 69.61% ， 同比 下降6.90% ；净利率为38.53%，同比下降 12.54%。 基本每股收益： 1.05元/股 。 三费（销售费用、管理费用、财务费用）总计为 6300.66万元 ，占总营收的比例从去年同期的9.72%上 升至18.97%，增幅达95.05%。 其中， 销售费用 同比增长 ...